受强制性开放获取政策约束的文章 - John J. Powers了解详情
无法在其他位置公开访问的文章：1 篇
Circumventing immune tolerance through epigenetic modification
JA Dubovsky, A Villagra, JJ Powers, HW Wang, J Pinilla-Ibarz, ...
Current pharmaceutical design 16 (3), 268-276, 2010
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：30 篇
Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of …
T Knox, E Sahakian, D Banik, M Hadley, E Palmer, S Noonepalle, J Kim, ...
Scientific reports 9 (1), 6136, 2019
强制性开放获取政策： US National Institutes of Health
Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation
KV Woan, M Lienlaf, P Perez-Villaroel, C Lee, F Cheng, T Knox, ...
Molecular oncology 9 (7), 1447-1457, 2015
强制性开放获取政策： US National Institutes of Health
Essential role of HDAC6 in the regulation of PD-L1 in melanoma
M Lienlaf, P Perez-Villarroel, T Knox, M Pabon, E Sahakian, J Powers, ...
Molecular oncology 10 (5), 735-750, 2016
强制性开放获取政策： US National Institutes of Health
Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function
E Sahakian, JJ Powers, J Chen, SL Deng, F Cheng, A Distler, DM Woods, ...
Molecular immunology 63 (2), 579-585, 2015
强制性开放获取政策： US National Institutes of Health
TGF-β-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures
RA Chaurio, CM Anadon, TL Costich, KK Payne, S Biswas, CM Harro, ...
Immunity 55 (1), 115-128. e9, 2022
强制性开放获取政策： US National Institutes of Health
Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells
CM Anadon, X Yu, K Hänggi, S Biswas, RA Chaurio, A Martin, KK Payne, ...
Cancer Cell 40 (5), 545-557. e13, 2022
强制性开放获取政策： US National Institutes of Health
Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice
CL Kriss, JA Pinilla-Ibarz, AW Mailloux, JJ Powers, CHA Tang, CW Kang, ...
Blood, The Journal of the American Society of Hematology 120 (5), 1027-1038, 2012
强制性开放获取政策： US National Institutes of Health
WT 1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides
J Brayer, JE Lancet, J Powers, A List, L Balducci, R Komrokji, ...
American journal of hematology 90 (7), 602-607, 2015
强制性开放获取政策： US National Institutes of Health
T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine model
DM Woods, KV Woan, F Cheng, AL Sodré, D Wang, Y Wu, Z Wang, ...
Blood, The Journal of the American Society of Hematology 130 (2), 146-155, 2017
强制性开放获取政策： US National Institutes of Health
The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells
K Maharaj, JJ Powers, A Achille, M Mediavilla-Varela, W Gamal, ...
Blood advances 4 (13), 3072-3084, 2020
强制性开放获取政策： US National Institutes of Health
Essential role for histone deacetylase 11 (HDAC11) in neutrophil biology
E Sahakian, J Chen, JJ Powers, X Chen, K Maharaj, SL Deng, AN Achille, ...
Journal of leukocyte biology 102 (2), 475-486, 2017
强制性开放获取政策： US National Institutes of Health
A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease
K Sweet, L Hazlehurst, E Sahakian, J Powers, L Nodzon, F Kayali, ...
Leukemia research 74, 89-96, 2018
强制性开放获取政策： US National Institutes of Health
HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms
L Yue, V Sharma, NP Horvat, AA Akuffo, MS Beatty, C Murdun, C Colin, ...
Blood, The Journal of the American Society of Hematology 135 (3), 191-207, 2020
强制性开放获取政策： US National Institutes of Health, US Department of Veterans Affairs
A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors
JJ Powers, JA Dubovsky, PK Epling-Burnette, L Moscinski, L Zhang, ...
Leukemia & lymphoma 52 (4), 668-679, 2011
强制性开放获取政策： US National Institutes of Health
IgA-dominated humoral immune responses govern patients' outcome in endometrial cancer
G Mandal, S Biswas, CM Anadon, X Yu, CD Gatenbee, S Prabhakaran, ...
Cancer research 82 (5), 859-871, 2022
强制性开放获取政策： US National Institutes of Health
Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiers
JA Dubovsky, D Wang, JJ Powers, E Berchmans, MA Smith, KL Wright, ...
Leukemia research 35 (3), 394-404, 2011
强制性开放获取政策： US National Institutes of Health
Olfactory receptor OR2H1 is an effective target for CAR T cells in human epithelial tumors
AL Martin, CM Anadon, S Biswas, JA Mine, KF Handley, KK Payne, ...
Molecular cancer therapeutics 21 (7), 1184-1194, 2022
强制性开放获取政策： US National Institutes of Health
HDAC6 inhibition alleviates CLL-induced T-cell dysfunction and enhances immune checkpoint blockade efficacy in the Eμ-TCL1 model
K Maharaj, JJ Powers, M Mediavilla-Varela, A Achille, W Gamal, S Quayle, ...
Frontiers in Immunology 11, 590072, 2020
强制性开放获取政策： US National Institutes of Health
Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia
K Maharaj, JJ Powers, A Achille, S Deng, R Fonseca, M Pabon-Saldana, ...
Blood advances 2 (21), 3012-3024, 2018
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定